Willingness to pay for depression treatment in primary care

Psychiatric Services

Volumn 54, Issue 3, 2003, Pages 340-345

  Unützer, Jürgen ^a   Katon, Wayne J ^b   Russo, Joan ^b   Simon, Gregory ^c   Von Korff, Michael ^c   Lin, Elizabeth ^c   Walker, Edward ^b   Ludman, Evette ^c   Bush, Terry ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PROSPECTIVE PAYMENT; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; DISEASE MANAGEMENT; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH MAINTENANCE ORGANIZATION; HEALTH SERVICES RESEARCH; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SOCIOECONOMICS; UNITED STATES;

ANTIDEPRESSANT AGENT;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DISEASE MANAGEMENT; FEMALE; FINANCING, PERSONAL; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; PSYCHOTHERAPY; VALUE OF LIFE; WASHINGTON;

EID: 85047689282     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.54.3.340     Document Type: Article

References (52)

1. Agency for Health Care Policy and Research Depression Guidelines Panel: Depression in Primary Care: Clinical Practice Guideline No 5. Rockville, Md, Agency for Health Care Policy and Research, Pub No 93-0550, 1993
2. Katon W, Von Korff M, Lin E, et al: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273:1026-1031, 1995
3. Katon W, Robinson I, Von Korff M, et al: A multifaceted intervention to improve treatment of depression in primary care. Archives of General Psychiatry 27:932-934, 1996
4. Katon W, Von Korff M, Lin EHB, et al: Stepped collaborative care for primary care patients with persistent symptoms of depression. Archives of General Psychiatry 56:1109-1115, 1999
5. Simon GE: Cost-effectiveness of improved depression treatments. Presented at NIMH Conference on Challenges for the 21st Century: Mental Health Services Research, Washington, DC, July 18, 2000
6. Hunkeler EM, Meresman J, Hargreaves WA, et al: Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Archives of Family Medicine 9:700-708, 2000
7. Schulberg HC, Block MR, Madonia MJ, et al: Treating major depression in primary care practice: eight-month clinical outcomes. Archives of General Psychiatry 53: 913-919, 1996
8. Katzelnick DJ, Simon GE, Pearson SD, et al: Randomized trial of a depression management program in high utilizers of medical care. Archives of Family Medicine 9:345-351, 2000
9. Kroenke K, West SL, Swindle R, et al: Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 286:2947-2955, 2001
10. Lave JR, Frank RG, Schulberg HC, et al: Cost-effectiveness of treatments for major depression in primary care practice. Archives of General Psychiatry 55:645-651, 1998
11. Von Korff M, Katon W, Bush T, et al: Treatment cost, cost-offset, and cost-effectiveness of collaborative management of depression. Psychosomatic Medicine 60:143-149, 1998
12. Johannesson M, Johansson PO, Josson B: Economic evaluation of drug therapy: a review of the contingent valuation method. Pharmacoeconomics 1:325-337, 1992
13. O'Brien BJ, Viramontes JL: Willingness to pay: a valid and reliable measure of health state preference? Medical Decision Making 14:289-297, 1994
14. O'Brien BJ, Novosel S, Torrance G, et al: Assessing the economic value of a new antidepressant: a willingness to pay approach. Pharmacoeconomics 8:34-45, 1995
15. Ramsey S, Sullivan SD, Psaty BM, et al: Willingness to pay for antihypertensive care: evidence from a staff model HMO. Social Science and Medicine 44:1911-1917, 1994
16. Flowers CR, Garber AM, Bergen MR, et al: Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems, in The Emergence of Internetable Health Care: Systems that Really Work: Proceedings of the 1997 AMIA Annual Symposium. Edited by Masys DR. Bethesda, Md, American Medical Informatics Association, 1997
17. Frederick AM, Chey WD, Magaret N, et al: Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. American Journal of Medicine 107:133-136, 1999
18. Golan EH, Shechter M: Contingent valuation of supplemental health care in Israel. Medical Decision Making 13:302-310, 1993
19. Gafni A: Willingness to pay as a measure of benefits. Medical Care 29:1246-1252, 1991
20. Gafni A: Alternatives to the QALY measure for economic evaluations. Supportive Care in Cancer 5:105-111, 1997
21. Thompson MS, Read JL, Liang M: Feasibility of willingness-to-pay measurement in chronic arthritis. Medical Decision Making 4:195-215, 1984
22. Johannesson M, Jonsson B: Willingness to pay for antihypersensitive therapy: results of a Swedish pilot study. Journal of Health Economics 10:461-474, 1991
23. Olsen JA, Donaldson C: Helicopters, hearts, and hips: using willingness to pay to set priorities for public sector health care programmes. Social Science and Medicine 46:1-12, 1998
24. Chestnut LG, Keller LR, Lambert WE, et al: Measuring heart patients' willingness to pay for changes in angina symptoms. Medical Decision Making 16:65-77, 1996
25. Taylor SJ, Armour CL: Measurement of consumer preference for treatments used to induce labour: a willingness to pay approach. Health Expectations 3:203-216, 2000
26. Olsen JA, Smith RD: Theory versus practice: a review of willingness-to-pay in health and health care. Health Economics 10:39-52, 2001
27. Longo CJ: Choices of methodology in pharmacoeconomics studies. Medical Care 37(4 suppl Lilly):32-35, 1999
28. Smith RD: The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation. Health Economics 10:487-497, 2001
29. Voruganti LN, Awad AG, Oyewumi LK, et al: Assessing health utilities in schizophrenia: a feasibility study. Pharmacoeconomics 17:273-286, 2000
30. Katon WJ, Rutter C, Ludman E, et al: A randomized trial of relapse prevention of depression in primary care. Archives of General Psychiatry 56:1109-1115, 1999
31. Diener A, O'Brien B, Gafni A: Health care contingent valuation studies: a review and classification of the literature. Health Economist 7:313-326, 1998
32. Williams JB, Gibbon M, First MB, et al: The structured clinical interview for DSMIII-R (SCID), part 2: multisite test-retest reliability. Archives of General Psychiatry 49:630-636, 1992
33. Derogatis LR, Rickels K, Uhlenhuth EH, et al: The Hopkins symptom checklist: a measure of primary symptom dimensions, in Psychological Measurements in Psychopharmacology: Problems in Pharmacopsychiatry. Edited by Pichot P. Basel, Switzerland, Karger, 1974
34. Simon GE, Revicki D, Von Korff M: Telephone assessment of depression severity Journal of Psychiatric Research 27:247-252, 1993
35. Costa PT, McCrae RR: The NEO Personality Inventory Manual. Odessa, Fla, Psychological Assessment Resources, 1985
36. Katon W, Lin E, Von Korff M, et al: The predictors of persistence of depression in primary care. Journal of Affective Disorders 31:81-90, 1994
37. Von Korff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology 45:197-203, 1992
38. Blumenschein K, Johannesson M: Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Annals of Allergy, Asthma, and Immunology 80:189-194, 1998
39. Lundberg L, Johanneson M, Silverdahl M, et al: Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. British Journal of Dermatology 141:1067-1075, 1999
40. Frew E, Wolstenholme JL, Whynes DK: Willingness-to-pay for colorectal cancer screening. European Journal of Cancer 37:1746-1751, 2001
41. Simon GE, Unützer J: Health care utilization by patients treated for bipolar disorder in an insured population. Psychiatric Services 50:1303-1308, 1999
42. Lave JR, Frank RG, Schulberg HC, et al: Cost-effectiveness of treatments for major depression in primary care practice. Archives of General Psychiatry 55:645-651, 1998
43. Simon GE, Katon WJ, Von Korff M, et al: Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. American Journal of Psychiatry 158:638-644, 2001
44. Blumenschein K, Johannesson M, Yokohama KK, et al: Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. Journal of Health Economics 20:441-457, 2001
45. O'Connor RM, Johannesson M, Hass SL, et al: Urge incontinence: quality of life and patients' valuation of symptom reduction. Pharmacoeconomics 14:531-539, 1998
46. Klose T: The contingent valuation method in health care. Health Policy 47:97-123, 1999
47. Sherbourne CD, Keeler E, Unützer J, et al: Relationship between age and patients' current health state preferences. Gerontologist 39:271-278, 1999
48. Sherbourne CD, Schoenbaum M, Unützer J, et al: Can utility-weighted HRQOL estimates capture health effects of quality improvement for depression? Medical Care 29:1246-1259, 2001
49. Wells KB, Sherbourne CD: Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Archives of General Psychiatry 56:897-904, 1999
50. Schulberg HC: Treating depression in primary care practice: applications of research findings. Journal of Family Practice 50: 535-537, 2001
51. Wells KB, Schoenbaum M, Unützer J, et al: Quality of care for depression in managed care. Archives of Family Medicine 8: 529-536, 1999
52. Young AS, Klap R, Sherbourne CD, et al: The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry 58:55-61, 2001